By: Laura Cowen From: insideprecisionmedicine. Researchers at the University of Cambridge and The Institute of Cancer Research in London have shown that the current UK National Institute for Health and Care Excellence (NICE) breast cancer risk assessment criteria miss over 95% of women under 50 years of age who will develop the disease within 10 years. Compared with the multifactorial …
Humble yourselves before …
Humble yourselves before the Lord, and he will lift you up. James 4:10 Barbara JacobyBarbara Jacoby is an award winning blogger that has contributed her writings to multiple online publications that have touched readers worldwide. LetLifeHappen.com
What Are the Side Effects of Breast Cancer Treatment?
From: healthline.com Side effects of breast cancer treatment often go away once treatment is over, but some can be long term. Side effect management might include home remedies and prescription medications. Breast cancer treatment options vary widely from person to person. Most people undergo some kind of surgery, but many also receive other treatments, such as chemotherapy, radiation, hormone therapy, …
Breast Cancer and Bone Density: What You Need to Know
By Korin Miller From: .bcrf.org There’s a lot to consider about your health while undergoing treatment for breast cancer. But while fertility and hair preservation tends to get the most attention, bone health can also be impacted by breast cancer treatments. Breast cancer itself doesn’t usually reduce bone density, which is a term used to describe the amount of minerals …
Leptomeningeal Disease in HER2-Positive Metastatic Breast Cancer
By: Mike Basset From: medpagetoday.com About 110,000 new cases of leptomeningeal disease (metastases of cerebrospinal fluid or the thin membranes that surround the brain and spinal cord) are diagnosed each year in the U.S., with the incidence varying among cancer types. Among breast cancer patients, incidence ranges between 5% and 8% . Patients with HER2-positive status are at particularly high …
A step-by-step guide to physical and visual breast exams
Early detection plays a key role in protecting your health when it comes to breast cancer (or any type of cancer). Screening mammograms should start at age 40, but recommendations may vary across organizations and depending on factors, including whether you have a gene mutation, denser breast tissue, or a family history of breast cancer. Here’s how to perform a …
Chemotherapy for the Breast Cancer Patient and the Insurance Companies
View PostFDA Green-Lights Five New Treatment Options for Breast Cancer
By: Liz Highleyman From: cancerhealth.com The Food and Drug Administration (FDA) recently approved several new therapies for breast cancer, including for patients with metastatic (Stage IV) cancer and hard-to-treat triple-negative breast cancer (TNBC). Because treatment is continually evolving, it is often possible to move on to new medications if current ones stop working. Breast cancer, classified by the type of …
Gedatolisib Combinations Nearly Double PFS in PIK3CA-Mutant Breast Cancer
By:Sara A. Hurvitz, MD, Sabrina Seran From: targetedonc.com On July 14, 2026, the FDA approved gedatolisib (Revtorpyk) in combination with fulvestrant (Faslodex), with or without palbociclib (Ibrance), for adults with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer without a PIK3CA mutation, based on results from Study 1 of the phase 3 VIKTORIA-1 trial (NCT05501886).1 Gedatolisib is the …
New Breast Cancer Study Offers Hope for Less Swelling
From: breastadvocateapp.com For many women with breast cancer, treatment doesn’t end after the tumor is removed. Decisions about lymph node treatment can have a lasting impact on recovery and quality of life. Now, new research presented at the 15th European Breast Cancer Conference (EBCC 2026) suggests that radiotherapy may help some patients avoid more extensive lymph node surgery while reducing their risk of …